{
  "abstract": "The National Institute for Health and Care Excellence (NICE) has recommended betula verrucos (Itulazax), a once daily immunotherapy tablet for people with moderate to severe allergic rhinitis or conjunctivitis (hay fever) caused by birch tree pollen.",
  "authors": [
    {
      "affiliations": [
        "The BMJ"
      ],
      "name": "Kate Bowie"
    }
  ],
  "title": "Sixty seconds on . . . pollen immunotherapy",
  "uid": "57895080-458d-5e95-846b-a33830583bf4"
}